Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Direct costs attributable to producing goods sold
3Y CAGR
-9.4%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $245000.00 | -5.0% |
| 2024 | $258000.00 | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $329000.00 | - |
| 2021 | $0.00 | - |